Fenofibrate - Induced myopathy in a patient with undiagnosed hypothyroidism - Case report and a review of the literature;Miopatia spowodowana stosowaniem fenofibratu u osoby z nierozpoznana̧ niedoczynnościa̧ tarczycy - Opis przypadku i przegla̧d piśmiennictwa

Polskie Archiwum Medycyny Wewnetrznej

Volumn 115, Issue 1, 2006, Pages 45-49

  Łukjanowicz, Małgorzata ^a   Trzcińska Butkiewicz, Beata ^a   Brzosko, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Fenofibrate; Fenofibrate induced myopathy; Hypothyroid myopathy; Hypothyroidism; Rhabdomyolysis

Indexed keywords

CREATININE; FENOFIBRATE; LEVOTHYROXINE; MUSCLE ENZYME;

ADULT; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG EFFECT; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; MYOPATHY; REVIEW;

EID: 33745900241     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Lang J., Wang P., Glueck C.: Myopathy associated with lipid lowering therapy in patients with previously undiagnosed or undertreated hypothyroidism. Clin. Chim. Acta, 1996, 254, 1, 65.
2. Górowski T.: Rozdz. 11. Niedoczynność tarczycy. Choroby tarczycy. PZWL, Warszawa, 1989, 248.
3. Diekman T., Lansberg P., Kastelein J., Wiersinga W.: Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch. Intern. Med., 1995, 155, 14, 1490.
4. O'Kane M., Neely R., Trimble E., Nicholls D.: The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic. Ann. Clin. Biochem., 1991, 28, 5, 509.
5. Glueck C., Lang J., Tracy T., Speirs J.: The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin. Chim. Acta, 1991, 14, 201, 113.
6. McKeran R.O., Slavin G., Ward P., Paul E., Mair W.G.: Hypothyroid myopathy. A clinical and pathological study. J. Pathol., 1980, 132, 1, 35.
7. Khaleeli A.A., Griffith D.G., Edwards R.H.: The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin. Endocrinol., 1983, 19, 3, 365.
8. Norris F.H. Jr., Panner B.J.: Hypothyroid myopathy. Clinical, electromyographical, and ultrastructural observations. Arch. Neurol., 1966, 14, 6, 574.
9. Madariaga M.G.: Polymyositis-like syndrome in hypothyroidism: review of cases reported over the past twenty-five years. Thyroid, 2002, 12, 4, 331.
10. Hochberg M.C., Koppes G.M., Edwards C.Q., Barnes H.V., Arnett F.C. Jr.: Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum., 1976, 19, 6, 1363.
11. Beyer I.W., Karmali R., Demeester-Mirkine N., Cogan E., Fuss M.J.: Serum creatine kinase levels in overt and subclinical hypothyroidism. Thyroid, 1998, 8, 11, 1029.
12. Przygodzka M.: Stawowa manifestacja chorób tarczycy. Terapia, 2003, 10, 143, 45.
13. Ciompi M., Zuccotti M., Bazzichi L., Puccetti L.: Polymyositis-like syndrome in hypothyroidism: report of two cases. Thyroidology, 1994, 6, 1, 33.
14. Finsterer J.: Fibrat/Statin-Myopathie. Nervenarzt, 2003, 74, 2, 115.
15. Guay D.R.: Micronized fenofibrate: a new fibric acid hypolipidemic agent. Ann. Pharmacother., 1999, 33, 10, 1083.
16. Szumilak D., Sułowicz W, Walatek B.: Rabdomioliza: obraz kliniczny, przyczyny, powikłania i leczenie. Przegl. Lek., 1998, 55, 5, 274.
17. Duda-Król W., Jórasz I., Da̧browska M., Polubiec A., Kusz-Rynkun A.: Wstrza̧s toksyczno-septyczny w przebiegu rabdomiolizy u chorej leczonej fenofibratem. Wiad. Lek., 2000, 53, 7-8, 454.
18. Langer T., Levy R.I.: Acute muscular syndrome associated with administration of clofibrate. N. Engl. J. Med., 1968, 279, 16, 856.
19. Al-Jubouri M., Briston P., Sinclair D., Chinn R., Young R.: Myxoedema revealed by simvastatin induced myopathy. B. M. J., 1994, 308, 6928, 588.
20. Prudhomme F., Jacotot B.: Muscular toxicity of antilipemic agents revealed during the course of hypothyroidism. Presse Med., 2003, 32, 22, 1031.
21. Biernat E., Chwalińska-Sadowska H., Jȩdryka-Góral A., Wagner T.: Uszkodzenie miȩśni indukowane najprawdopodobniej simwastatyna̧ u chorej z ksantomatoza̧ w przebiegu hiperlipidemii typu IIB. Reumatologia, 1995, 33, 3, 314.
22. Clouatre Y., Leblanc M., Ouimet D., Pichette V.: Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism. Nephrol. Dial. Transplant., 1999, 14, 4, 1047.
23. Hattori N., Shimatsu A., Murabe H., Nishimura M., Nakamura H., Imura H.: Clofibrate-induced myopathy in a patient with primary hypothyroidism. Jpn. J. Med., 1990, 29, 5, 545.
24. Tregouet B.: Does hypothyroidism predispose muscular toxicity of fibrates? Rev. Med. Interne, 1991, 12, 2, 159.
25. Wechsler B., Doumith R., Weil M.: Myosite, hypothyroidie et fibrates. Rev. Med. Interne, 1991, 12, 6, 475.
26. Hung Y., Yeung V.: Hypothyroidism presenting as hypercholesterolaemia and simvastatin-induced myositis. Hong Kong Med. J., 2000, 6, 4, 423.